# Combination Therapy in Indian Visceral Leishmaniasis

> **NCT00523965** · PHASE3 · COMPLETED · sponsor: **Banaras Hindu University** · enrollment: 624 (estimated)

## Conditions studied

- Leishmaniasis, Visceral

## Interventions

- **DRUG:** amphotericin B deoxycholate
- **DRUG:** Liposomal Amphotericin B with Miltefosine
- **DRUG:** Liposomal Amphotericin B and Paromomycin Sulfate
- **DRUG:** miltefosine + Paromomycin sulfate

## Key facts

- **NCT ID:** NCT00523965
- **Lead sponsor:** Banaras Hindu University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-08
- **Final completion:** 2010-02
- **Target enrollment:** 624 (ESTIMATED)
- **Last updated:** 2010-05-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523965, "Combination Therapy in Indian Visceral Leishmaniasis". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT00523965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*